AI's Two Speeds: Why Biomedicine Is Leaping Forward While Business Lags Behind
Artificial intelligence is accelerating biomedical discovery at a pace that seemed like science fiction just a few years ago. Where creating a new antibody, sequencing a protein, or detecting a tumor once took years, millions of dollars, and dozens of specialists, it now requires mere hours or weeks, driven by automation and radically different budgets. Consider these breakthroughs from June alone: ...